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Abstract
Three simple and rapid spectrophotometric methods were developed for detection and trace determination of
benzophenone (the main impurity) in phenytoin bulk powder and pharmaceutical formulations. The first method,
zero-crossing first derivative spectrophotometry, depends on measuring the first derivative trough values at 257.6
nm for benzophenone. The second method, zero-crossing third derivative spectrophotometry, depends on
measuring the third derivative peak values at 263.2 nm. The third method, ratio first derivative spectrophotometry,
depends on measuring the peak amplitudes of the first derivative of the ratio spectra (the spectra of
benzophenone divided by the spectrum of 5.0 μg/mL phenytoin solution) at 272 nm. The calibration graphs were
linear over the range of 1-10 μg/mL. The detection limits of the first and the third derivative methods were found
to be 0.04 μg/mL and 0.11 μg/mL and the quantitation limits were 0.13 μg/mL and 0.34 μg/mL, respectively, while
for the ratio derivative method, the detection limit was 0.06 μg/mL and the quantitation limit was 0.18 μg/mL. The
proposed methods were applied successfully to the assay of the studied drug in phenytoin bulk powder and
certain pharmaceutical preparations. The results were statistically compared to those obtained using a
polarographic method and were found to be in good agreement.
Background
Phenytoin is a hydantoin antiepileptic used to control par-
tial and generalized tonic-clonic seizures. It has also been
used in treatment of trigeminal neuralgia and cardiac
arrhythmias [1]. Benzophenone can be used as fixative for
perfumes [2] and soaps, it prevents the ultraviolet (UV)
light from damaging scents and colors in products, It can
also be added to the plastic packaging as a UV blocker [3].
Benzophenone used in the manufacture of antihistamines,
hypnotics and insecticides [2] and so it considered as a
potential impurity in diphenhydramine hydrochloride
[4,5], phenytoin bulk powder [4,5] and phenytoin dosage
forms [4,5].
Benzophenone is irritating to the eyes, the skin and the
respiratory tract [6,7] and at excessive exposure, CNS dis-
turbance and coma may be noted [6]. Chhabra [8] and
Rhodes et al. [9] found that, the liver is a primary target
organ of benzophenone toxicity in rats and mice. The tox-
icological profile of benzophenone is similar to a number
of known hepatocarcinogens, suggesting that
benzophenone is a potential liver carcinogen. The kidney
was also identified as a target organ of benzophenone toxi-
city. Estrogenic and antiandrogenic activities of benzophe-
none were comparatively examined with hormone-
responsive reporter assay in various cell lines [10-12].
The United States Pharmacopoeia USP [5] recom-
mended HPLC procedures for the determination of ben-
zophenone as a main impurity in phenytoin. The BP [4]
specifies a TLC method to limit benzophenone in
phenytoin.
A review of the literature revealed that only one (polaro-
graphic) method has been published for the determination
of benzophenone, as an impurity, in phenytoin [13].
Although those methods offer a high degree of specificity,
the instrumentation limitations preclude their use in rou-
t i n ea n a l y s i s .T ot h eb e s to fo u rk n o w l e d g e ,n os p e c t r o -
photometric methods have been yet described for the
determination of benzophenone, as an impurity, in pheny-
toin. Therefore, it was desirable to develop a simple and
fast procedure that could be applied in quality control
laboratories for the determination of benzophenone, as an
impurity, in phenytoin.
Derivative spectrophotometry offers greater selectivity
than does normal spectrophotometry in the simultaneous
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vious chemical separation [14-16]. The principles and
advantages of this technique have been described by
O’Haver and Green [17].
Ratio derivative spectrophotometry is based on the use
of the first derivative of the ratio spectra. This method
was developed by Salinas et al [18]. Berzas Nevado et al.
extended this method to resolving ternary mixtures [19].
The present paper describes simple and rapid methods
for the determination of benzophenone, as impurity, in
phenytoin bulk powder and certain pharmaceutical pre-
parations by zero-crossing first derivative spectrophoto-
metry, zero-crossing third derivative spectrophotometry
and ratio first derivative spectrophotometry without
prior separation.
Experimental
Apparatus
Spectrophotometric analysis was carried out on a Shi-
madzu (Kyoto, Japan) UV-1601 PC, UV-Visible double-
beam spectrophotometer with matched 1-cm pathlength
quartz cells. Suitable settings were: Slit width, 1 nm; scan
speed, fast; sampling interval, auto.
The first derivative spectra of benzophenone were
derived in the wavelength range (250-350) nm using Δl =
2 nm and scaling factor = 100.
The third derivative spectra of the studied drug were
derived in the wavelength range (240-300) nm using Δl =
8 nm and scaling factor = 2000.
The ratio derivative spectra were derived in the wave-
length range (200-298) nm using Δl = 8 nm and scaling
factor = 1 for smoothing of ratio spectra and Δl =4
nm for the first derivative of ratio spectra with scaling
factor = 10.
Materials and reagents
All the chemicals used were of Analytical Reagent grade
and the solvents were of spectroscopic grade.
￿ Benzophenone was kindly provided by (El-Nasr
Pharmaceutical Chemicals Company (ADWIC),
Egypt). The purity of the sample was found to be
100.15 ± 0.36 which was determined by applying the
reported polarographic
(13) method.
￿ Phenytoin (Aldrich Chemical Co., Ltd., Dorset,
England).
￿ Phenytin
® ampoules (labeled to contain 100 mg
phenytoin sodium/2 mL ampoule, batch # 95040)
were manufactured in The Nile Co. for Pharmaceuti-
cals & Chemical Industries, Cairo, Egypt.
￿ Phenytin
® capsules (labeled to contain 100 mg
phenytoin sodium/capsule, batch # 36050) were
manufactured in The Nile Co. for Pharmaceuticals &
Chemical Industries, Cairo, Egypt.
￿ Ipanten
® capsules (labeled to contain 100 mg phe-
nytoin sodium/capsule, batch # AC1009) were man-
ufactured in ACDIMA International trading, Egypt.
￿ All Pharmaceutical preparations were purchased
from commercial sources.
￿ Methanol (Prolabo, France).
Standard solutions
Stock solutions (1.0 mg/mL) of each of benzophenone and
phenytoin were prepared by dissolving 10.0 mg of each in
methanol and completed to 10 mL with the same solvent.
Working standard solutions (100.0 μg/mL) were prepared
by subsequent dilution to 25 mL with methanol. An addi-
tional working solution (10.0 mg/mL) of phenytoin was
prepared by the same manner, to be used in the prepara-
tion of synthetic mixtures. The solutions were stable for at
least 7 days when kept in the refrigerator at 4°c.
Construction of the Calibration Graphs
Daily working standard solutions were prepared from the
previously prepared working standard solution by serial
dilutions with methanol to contain 1 - 10 μg/mL for ben-
zophenone and to contain 200 μg/mL for phenytoin (final
concentrations). The zero order absorption spectra were
recorded against a reagent blank (methanol).
The absolute values of the first order derivatives were
obtained by zero-crossing technique with measurements
at 257.6 nm for benzophenone.
For the determination by third derivative spectropho-
tometry, the absolute values of the third derivative were
measured at 263.2 nm.
For the determination by ratio derivative spectrophoto-
metry, the first derivative of the ratio spectra (the spectra
of benzophenone divided by the spectrum of 5.0 μg/mL
phenytoin solution) was recorded. The amplitudes at 272
nm were measured.
The derivative amplitudes were then plotted against
the final concentrations to get the calibration graphs.
Alternatively, the corresponding regression equations
were derived.
Application of the Proposed Methods to the Analysis of
Benzophenone in Prepared Synthetic Mixtures
Accurately measured aliquots of the suitable working
standard solutions of both drugs were transferred into a
series of 10-mL volumetric flasks to prepare different
synthetic mixtures of benzophenone and phenytoin in
the ratios of 0.5% (the BP [4] limits of benzophenone in
phenytoin) and 0.1% (the USP [5] limits of benzophenone
in phenytoin). The solutions were then diluted with
methanol to volume, mixed and aliquots containing sui-
table concentrations were taken and analyzed as
described under construction of the calibration graphs.
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using, either the calibration curve or the corresponding
regression equation.
Application of the Proposed Methods to the Analysis of
Added Benzophenone in Phenytoin Dosage Forms
Capsules
An accurately weighed quantity of the mixed contents of
10 capsules equivalent to 0.5 g of phenytoin was trans-
ferred into a small conical flask, and then extracted by
sonication for 15 minutes with 15 mL of methanol and fil-
tering into 50-mL volumetric flask. Repeat the extraction
with further two 15-mL portions of methanol. The conical
flask was washed with several milliliters of methanol. The
washings were passed into the same volumetric flask and
completed to the volume with the same solvent. The
above procedure under application of the proposed meth-
ods to the analysis of benzophenone in prepared synthetic
mixtures was then followed. The nominal content was cal-
culated either from the previously plotted calibration
graph or using the corresponding regression equation.
Ampoules
An accurately measured volume of mixed content of 10
ampoules equivalent to 1.0 g of phenytoin base transferred
into 100-mL volumetric flask, and then diluted to the
mark with methanol. The above procedure under applica-
tion of the proposed methods to the analysis of benzophe-
none in prepared synthetic mixtures was then followed.
The nominal content was calculated either from the pre-
viously plotted calibration graph or using the correspond-
ing regression equation.
Results and discussion
The BP [4] limits are 0.5% for benzophenone in bulk pow-
der and in, capsules and ampoules of phenytoin, whereas,
the USP [5] limits are 0.1% for the studied drug in pheny-
toin bulk powder. Moreover the specific absorbance of
phenytoin (the major component) is higher than the speci-
fic absorbance of benzophenone (the minor component).
So, the analysis of such mixture by conventional spectro-
photometry was challenging.T h e r e f o r e ,w er e s o r t e dt o
first derivative, third derivative and ratio first derivative
spectrophotometry in an attempt to detect and determine
benzophenone (the main impurity) in phenytoin.
Dilution with different solvents such as 0.1 M HCl, 0.1
M NaOH, methanol and acetonitrile were tried for per-
formance investigations. It was found that; methanol
was the best solvent for dilution as it gave the highest
sensitivity with good shaped spectrum.
Figure 1(a, b) shows the absorption spectra of benzo-
phenone and phenytoin in methanol which overlap suf-
ficiently to demonstrate the resolving power of the
proposed methods.
’Zero-crossing’ first derivative spectrophotometry
Because the derivative spectrophotometric technique
enhances the detectability of the minor features of the
UV absorption spectrum, the first derivative spectra of
both benzophenone and phenytoin (Figure 2) displays
features which may permit more specific and selective
determination of the benzophenone in the presence of
phenytoin. The zero-crossing method is the most com-
mon procedure for conducting analytical calibration in
derivative spectrophotometry, so benzophenone was
determined by measurement of its first derivative ampli-
tude at the zero-crossing of phenytoin at 257.6 nm
(
1D257.6;
order derivativeDerivativewavelength measure).
Figure 2 shows the first derivative spectra of benzo-
phenone in concentration range of 1-10 μg/mL with
constant phenytoin concentration (200 μg/mL).
’Zero-crossing’ third derivative spectrophotometry
Second and fourth derivative spectra were scanned but a
reproducible zero crossing point could not be found.
Figure 3 shows the third derivative spectra of benzophe-
none which could be determined by measurement of its
third derivative amplitude at the zero-crossing of pheny-
toin at 259 nm (
3D259), or at 263.2 nm (
3D263.2) both
with the same sensitivity.
Ratio first derivative spectrophotometry
Figure 4 shows the ratio spectra of different concentra-
tions of benzophenone (spectra divided by the spectrum
of a 5 μg/mL of phenytoin) while, Figure 5 shows their
first derivatives. As it can be seen, the amplitude at
272 nm (
1DD272;
order derivativeDerivative Dividedwavelength
measure) in the ratio derivative spectra corresponds to
benzophenone present in the solution, so it can be used
for its quantitative determination. The influence of Δl
for obtaining the first derivative of the ratio spectra was
tested to obtain the optimum wavelength interval; Δl =
4 nm was considered as suitable for this. For selecting
the standard solution as divisor, different concentrations
were tested and different calibration curves were
obtained.
The best results in terms of signal-to-noise ratio, sen-
sitivity and repeatability were obtained by using the
spectrum of 5 μg/mL phenytoin solution as divisor in
the determination of benzophenone.
To ensure the validity of the proposed methods, the
results were compared with those of a comparison dif-
ferential pulse (DPP) polarographic method [13]. How-
ever USP [5] recommends an HPLC method as limit
test for benzophenone in bulk drug only, while BP [4]
recommends a thin-layer (TLC) chromatographic
method as a limit test for benzophenone in phenytoin
bulk powder and dosage forms.
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Page 3 of 10The results of the three proposed methods showed no
significant differences with those obtained by the com-
parison polarographic method [13] as regards to accu-
racy and precision [20].
Validation
Linearity and Range
The calibration graphs for the determination of benzo-
phenone by the proposed methods were constructed by
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Figure 1 A: Zeroth derivative spectra of 1 μg/mL benzophenone (–) and 200 μg/mL phenytoin (......) in methanol. B: Zeroth derivative
spectra of 1 μg/mL benzophenone (–) and 5 μg/mL phenytoin (......) in methanol.
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Page 4 of 10plotting the derivative amplitudes versus the concentra-
tions as shown in Figures 6, 7 and 8. The graphs were
found to be rectilinear over the concentration ranges
cited in Table 1.
Statistical analysis [20] of the data gave high values of
correlation coefficients (r) of the regression equations,
small values of the standard deviations of residuals (Sy/x),
of intercept (Sa), and of slope (Sb), and small values of
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Figure 2 First derivative absorption spectra of benzophenone and 200 μg/mL phenytoin (......) in methanol.
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Figure 3 Third derivative spectrum of phenytoin (200 μg/mL)
and Series of third derivative spectra with varying
concentrations of benzophenone (1- 10 μg/mL).
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Figure 4 Ratio spectra of benzophenone when 5 μg/mL
phenytoin is used as divisor.
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Page 5 of 10percentage relative standard deviation and percentage
relative error (Table 1). These data proved the linearity of
the calibration graphs and the agreement of the results
with Beer’s law.
Accuracy and Precision
To prove the accuracy of the proposed methods, the
results of the assay of benzophenone as impurities in
phenytoin bulk powder and its pharmaceutical prepara-
tions were compared with those of a reported compari-
son polarographic method [13]. Moreover, several
synthetic mixtures in BP [4] and USP [5] limits ratio
were also analyzed. Statistical analysis [20] of the results
obtained by the proposed and comparison method using
Student’s t-test (t) and variance ratio F-test (F) showed
no significant differences between them regarding accu-
racy and precision, respectively (Tables 2, 3 and 4).
Intraday (repeatability) and inter-day (intermediate) pre-
cisions were assessed using three concentrations and
three replicates of each concentration. The relative
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Figure 5 First derivative of the ratio spectra of benzophenone
when 5 μg/mL phenytoin is used as divisor.
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Figure 6 Calibration curves for the determination of benzophenone by zero-crossing first derivative spectrophotometric method at
257.6 nm zero-crossing wavelength.
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Page 6 of 10standard deviations were found to be very small indicat-
ing reasonable repeatability and intermediate precision
of the proposed methods (Table 5).
Specificity
The specificity of each of the proposed methods was
investigated by observing any interference encountered
from common dosage form excipients. It was shown
that these compounds did not interfere with the results
of the proposed methods (Table 4).
Limit of Detection (LOD) and Limit of Quantitation (LOQ)
The limit of quantitation (LOQ) was determined by
establishing the lowest concentration that can be mea-
sured according to ICH Q2)R1) recommendation [21]
below which the calibration graph is non linear while
the limit of detection (LOD) was determined by evaluat-
ing the lowest concentration of the analyte that can be
readily detected. The results are shown in Table 1. LOQ
and LOD were calculated according to the following
equations [21]:
LOQ = 10 Sa/b
LOD = 3.3 Sa/b
Where Sa is the standard deviation of the intercept of
r e g r e s s i o nl i n e ,a n dbi st h es l o p eo ft h ec a l i b r a t i o n
curve.
Ruggedness
To examine the ruggedness of the procedures, the intra-
day and inter-day precisions were evaluated as shown in
Table 5. The precisions of the proposed methods were
fairly high, as indicated by the low values of percentage
relative standard deviation (% RSD) for the studied
drugs.
Applications
Analysis of Synthetic Mixtures
The proposed methods were successfully applied to the
analysis of benzophenone in synthetic mixtures contain-
ing the BP [4] and USP [5] limits of benzophenone in
phenytoin. The average percent recoveries were based
on the average of three replicate determinations. The
results obtained were in good agreement with those
obtained by the comparison polarographic method [13].
The results are shown in Table 3.
Analysis of Dosage Forms
The proposed methods were successfully applied to the
assay of benzophenone (by spiking) in phenytoin
ampoules and capsules. The average percent recoveries
of different concentrations were based on the average of
three replicate determinations. The results obtained
showed non-significant differences with those obtained
by the comparison polarographic method [13] as shown
in Table 4.
Conclusions
The proposed methods could be utilized for the detec-
tion and determination of benzophenone, as impurity, in
phenytoin bulk powder and its pharmaceutical prepara-
tions using simple, reliable, rapid, and economical pro-
cedures. The zero-crossing derivative spectrophotometry
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Figure 7 Calibration curve for the determination of
benzophenone by zero-crossing third derivative
spectrophotometric method at 263.2 nm zero-crossing
wavelength.
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Figure 8 Calibration curve for the determination of
benzophenone by the ratio derivative spectrophotometric
method at 272 nm.
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Page 7 of 10Table 1 Analytical performance data of the calibration graphs for the determination of benzophenone by the
proposed methods
Parameter First derivative method (
1D) Third derivative method (
3D) Ratio derivative method (
1DD)
Wavelength l (nm) 257.6 263.2 272
Concentration range (μg/mL) 1-10 1-10 1-10
Intercept (a) 20.65 × 10
-3 1.98 × 10
-3 -0.67
Slope (b) 0.27 0.12 9.24
Correlation coefficient (r) 0.9999 0.9999 0.9999
Standard deviation of the residuals, Sy/x 4.77 × 10
-3 5.14 × 10
-3 0.21
Standard deviation of the intercept, Sa 3.71 × 10
-3 3.99 × 10
-3 0.16
Standard deviation of the slope, Sb 0.61 × 10
-3 0.66 × 10
-3 0.02
Relative standard deviation, % RSD 0.83 1.10 0.97
Percentage error, % Error 0.34 0.45 0.39
Limit of detection (LOD) (μg/mL) 0.04 0.11 0.06
Limit of quantitation (LOQ) (μg/mL) 0.13 0.34 0.18
DA
1% (dl.g
-1.cm
-1)
a 2655 1181 9.24 × 10
4
D ε (L.mol
-1.cm
-1)
b 4.83 × 10
4 2.15 × 10
4 1.68 × 10
7
a Specific absorbance of the derivative mode.
b Molar absorptivity of the derivative mode.
Table 2 Assay results for the determination of benzophenone in pure forms
Parameter Proposed method Comparison method
(13)
First derivative method (
1D) Third derivative method (
3D) Ratio derivative method (
1DD)
% Found
(a) 098.18 102.35 102.03 100.56
100.41 099.84 100.50 099.89
100.20 099.63 099.20 100.01
100.37 100.12 099.66
099.81 099.20 100.15
099.96 100.51 100.11
Mean (x ) ± S.D. 099.82 ± 0.83 100.27 ± 1.10 100.27 ± 0.97 100.15 ± 0.36
T 0.64 0.18 0.20
F 5.48 9.61 7.37
a The average of three determinations.
N.B. Tabulated t-value at P = 0.05 is 2.36, tabulated F-value at P = 0.05 is 19.30.
Table 3 Assay results for the determination of benzophenone in synthetic mixtures
Prepared
Ratio
Amount taken (μg/mL) % Found
a
Benzophenone Phenytoin Proposed method Comparison method
(13)
1D
3D
1DD
0.5% 1.0 200.0 101.63 100.69 099.12 099.60
2.0 400.0 100.94 102.06 098.69 100.98
3.0 600.0 099.83 099.94 099.72 098.98
x ± S.D. 100.08 ± 0.90 100.90 ± 1.07 099.18 ± 0.52 099.85 ± 1.02
T 1.20 1.22 1.02
F 1.27 1.10 3.92
0.1% 1.0 1000.0 099.69 098.56 100.20 099.60
2.0 2000.0 101.06 099.97 101.09 100.98
3.0 3000.0 098.91 100.09 099.93 098.98
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Page 8 of 10Table 3 Assay results for the determination of benzophenone in synthetic mixtures (Continued)
x ± S.D. 099.89 ± 1.08 099.54 ± 0.85 100.41 ± 0.61 099.85 ± 1.02
t 0.04 0.41 0.81
F 1.13 1.44 2.84
a The average of three determinations.
N.B. Tabulated t-value at P = 0.05 is 2.78, tabulated F-value at P = 0.05 is 19.00
Table 4 Assay results for the determination of added benzophenone in phenytoin pharmaceutical preparations
Dosage form % Found
(a) of Benzophenone(added)
Proposed method Comparison method
(13)
1D
3D
1DD
Phenytin
® ampoules 099.80 099.25 101.05 099.60
101.00 099.63 099.25 100.98
099.95 098.33 100.19 098.98
Mean (x ) ± S.D. 100.25 ± 0.65 099.07 ± 0.67 100.16 ± 0.90 099.85 ± 1.02
T 0.57 1.10 0.39
F 2.45 2.35 1.29
Phenytin
® capsules 099.00 102.04 100.92 099.60
099.80 101.69 099.33 100.98
099.95 100.06 099.92 098.98
Mean (x ) ± S.D. 099.58 ± 0.51 101.26 ± 1.05 100.06 ± 0.80 099.85 ± 1.02
T 0.41 1.66 0.27
F 4.02 1.07 1.62
Ipanten
® capsules 100.10 101.59 101.15 099.60
099.10 100.06 100.01 100.98
099.90 099.65 099.86 098.98
Mean (x ) ± S.D. 099.70 ± 0.53 100.43 ± 1.02 100.34 ± 0.71 099.85 ± 1.02
T 0.23 0.69 0.68
F 3.74 1.00 2.11
a The average of three separate determinations.
N.B. Tabulated t-value at P = 0.05 is 2.78, tabulated F-value at P = 0.05 is 19.00
Table 5 Accuracy and precision data for the determination of benzophenone by the proposed methods
Parameters First derivative method (
1D) Third derivative method (
3D) Ratio derivative method (
1DD)
Intra-day % Found
(a) 099.55 099.68 100.09
099.96 101.36 101.21
100.34 099.56 099.23
Mean (x ) 099.95 100.20 100.18
S.D. 0.39 1.00 0.99
%RSD 0.39 1.00 0.99
%Error 0.16 0.41 0.40
Inter-day 1
st day 100.10 102.06 100.31
2
nd day 100.90 101.59 098.99
3
rd day 101.98 100.66 100.11
Mean (x ) 100.99 101.43 099.80
S.D. 0.94 0.71 0.71
%RSD 0.94 0.70 0.71
%Error 0.38 0.29 0.29
N.B. Each result is the average of three separate determinations.
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Page 9 of 10is more rapid and simple than ratio derivative spectro-
photometry; however the ratio derivative spectrophoto-
metry has greater sensitivity and accuracy. The use of
standardized spectra as divisors minimizes experimental
errors and background noise.
These proposed methods could be regarded as useful
alternative to the official USP chromatographic, the BP
qualitative TLC and reported polarographic methods in
the routine quality control of pharmaceutical formula-
tions, allowing qualitative and quantitative determina-
tions to be simultaneously and rapidly achieved with a
relatively inexpensive instrumentation.
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